Tarceva Oral Tablet 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Tarceva: Oral tablet (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_21839.JPG
Tarceva 100mg Tab
Genentech Inc
Pill Identification: T 100 

What is this Medicine?

ERLOTINIB (er LOE ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat non-small cell lung cancer and pancreatic cancer.

In-Depth Information

Tarceva 100mg Tablet

NDC: 502420063
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Non-small Cell Lung Cancer (NSCLC), Pancreatic Cancer

Sometimes used for but not FDA approved for the following conditions:
Head And Neck Cancer

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Tarceva 100mg Tablet
Drug Image file DrugItem_21839.JPG
Genentech Inc
Pill Identification: T 100 
Shape: round
Color: white

Reported Side Effects for Tarceva 100mg Tablet

Decreased Appetite Incidence:
<9.0%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Abnormal Heart Rhythm Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Back Pain Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Chest Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Conjunctivitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<14.0%*
Severity: SEVERE
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Blood Clot Incidence:
<11.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
<4.0%*
Severity: SEVERE
Onset: DELAYED
Weight Loss Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<3.0%*
Severity: SEVERE
Onset: EARLY
Bowel Obstruction Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Joint Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Depression Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
<7.0%*
Severity: SEVERE
Onset: EARLY
Tired Incidence:
<18.0%*
Severity: SEVERE
Onset: EARLY
Fever Incidence:
<3.0%*
Severity: SEVERE
Onset: EARLY
Headache Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Hemolytic Anemia Incidence:
<1.4%*
Severity: SEVERE
Onset: DELAYED
High Bilirubin Level Incidence:
<11.0%*
Severity: SEVERE
Onset: DELAYED
Heart Attack Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Eye Incidence:
<12.0%*
Severity: SEVERE
Onset: EARLY
Itching Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Mouth Ulcers Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
<1.4%*
Severity: MODERATE
Onset: DELAYED
Dry Skin Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hole In Intestines Incidence:
0.2-0.4%*
Severity: SEVERE
Onset: DELAYED
Liver Failure Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
0.4-1.2%*
Severity: SEVERE
Onset: DELAYED
Lyell'S Syndrome Incidence:
0.4-1.2%*
Severity: SEVERE
Onset: DELAYED
Brain Attack Incidence:
0.6-2.5%*
Severity: SEVERE
Onset: EARLY
Lung Inflammation Incidence:
1.1%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
4.0-16.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
5.0-14.0%*
Severity: SEVERE
Onset: EARLY
Shortness Of Breath Incidence:
8.0-28.0%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
>30.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Tarceva 100mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and Tarceva 100mg Tablet(Erlotinib)
Grapefruit juice and Erlotinib(Erlotinib)
Avoid Grapefruit or Grapefruit juice while receiving Erlotinib treatment. Side effects from Erlotinib may get worse if you take Grapefruit Juice. Contact your health care provider if you experience rash, diarrhea, fatigue, breathing problems, nausea, vomiting, or other unusual effects.
Major Lifestyle Interaction
Tobacco and Tarceva 100mg Tablet(Erlotinib)
Tobacco and Erlotinib(Erlotinib)
Do not smoke while taking Erlotinib. Talk to your health care professiona if you are a smoker. Smoking may decrease erlotinib levels, causing your cancer therapy to not work as well for you. If you have been smoking and then stop smoking, you may need careful monitoring, Inform your prescriber of any change in smoking status. If you stop smoking, erlotinib levels can increase or you may experience side effects. An erlotinib dose adjustment may be necessary in some patients who smoke or who quit smoking; do not adjust the dose by yourself.
Pregnancy & Lactation Information
First Trimester

Class 3 - Risk Documented in Animals

Second Trimester

Class 3 - Risk Documented in Animals

Third Trimester

Class 3 - Risk Documented in Animals

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Tarceva

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5